Prime Medicine, Inc. (PRME)
Prime Medicine, Inc. (PRME) has reported earnings 14 times since Mar 09, 2023. The stock moves an average of ±5.40% the day after reporting, closing higher 21.4% of the time. Its largest post-earnings gain was +4.13% (Feb 28, 2025) and its largest decline was -10.61% (May 11, 2023). The next earnings report is predicted for 2026-08-07 (approximate).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
14
Avg Abs. Movement
±5.40%
Positive %
21.4%
Negative %
78.6%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| May 07, 2026 | ☀ PRE | $3.38 | $3.55 | $3.12 | 219,530 | -8.65% | open_in_new |
| Mar 03, 2026 | ☀ PRE | $4.46 | $4.51 | $4.23 | 3,808,700 | -9.23% | open_in_new |
| Nov 07, 2025 | ☀ PRE | $4.00 | $4.07 | $3.81 | 5,945,400 | -8.85% | open_in_new |
| Aug 07, 2025 | ☀ PRE | $4.04 | $4.14 | $3.68 | 6,621,100 | -9.58% | open_in_new |
| May 08, 2025 | ☀ PRE | $1.48 | $1.49 | $1.32 | 2,296,600 | -7.04% | open_in_new |
| Feb 28, 2025 | ☀ PRE | $2.41 | $2.55 | $2.52 | 974,200 | +4.13% | open_in_new |
| Nov 12, 2024 | ☽ POST | $4.30 | $4.43 | $4.32 | 1,047,300 | -8.33% | open_in_new |
| Aug 08, 2024 | ☀ PRE | $4.62 | $4.66 | $4.39 | 568,300 | -0.23% | open_in_new |
| May 10, 2024 | ☀ PRE | $5.92 | $6.02 | $5.61 | 402,500 | -1.92% | open_in_new |
| Mar 01, 2024 | ☀ PRE | $8.71 | $9.06 | $8.74 | 619,900 | +1.27% | open_in_new |
| Nov 03, 2023 | ☽ POST | $6.84 | $7.89 | $7.80 | 920,800 | -0.51% | open_in_new |
| Aug 07, 2023 | ☽ POST | $13.79 | $14.24 | $12.55 | 426,400 | +1.27% | open_in_new |
| May 11, 2023 | ☀ PRE | $13.67 | $14.04 | $12.55 | 432,800 | -10.61% | open_in_new |
| Mar 09, 2023 | ☀ PRE | $15.67 | $15.86 | $14.72 | 239,700 | -3.98% | open_in_new |
Earnings Count
14
Total earnings in dataset
Avg Abs. Movement
±5.40%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260608 | open_in_new SEC.gov |
| 4 | 20260608 | open_in_new SEC.gov |
| 4 | 20260608 | open_in_new SEC.gov |
| 4 | 20260608 | open_in_new SEC.gov |
| 4 | 20260608 | open_in_new SEC.gov |
| 4 | 20260608 | open_in_new SEC.gov |
| 4 | 20260608 | open_in_new SEC.gov |
| 8-K | 20260608 | open_in_new SEC.gov |
| 10-Q | 20260507 | open_in_new SEC.gov |
| 8-K | 20260507 | open_in_new SEC.gov |
Frequently asked about PRME earnings
When does Prime Medicine, Inc. report earnings next? expand_more
Prime Medicine, Inc. (PRME)'s next earnings date is approximate for 2026-08-07. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does PRME stock move after earnings? expand_more
Over 14 reports, PRME has moved an average of ±5.40% the session after earnings, closing higher 21.4% of the time.
What was PRME's biggest post-earnings move? expand_more
PRME's largest post-earnings gain on record was +4.13% on Feb 28, 2025, and its largest decline was -10.61% on May 11, 2023.
Where can I find Prime Medicine, Inc.'s SEC filings? expand_more
All of Prime Medicine, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right